Locations:

Tag: brian rini

January 30, 2019/Cancer/Research

Survival Rates Higher for Patients with Metastatic Renal Cancer at High-Volume Facilities

Study first to compare rates for mRCC medical oncology

October 24, 2018/Cancer/Research

IMmotion Update: Understanding the Biomarkers Behind Better Outcomes

Gene signatures differentiate clinical response

June 11, 2018/Cancer/Research

Multigene Assay Holds Prognostic Promise for Renal Cell Carcinoma

Identifying low and high risk of recurrence

June 3, 2018/Cancer/Research

IMmotion151 Reports Encouraging Results

New mRCC medication regimen effective and well tolerated

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 21, 2018/Cancer/Research

Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer

Positive results point to a better prognosis for intractable disease

January 3, 2018/Cancer/Research

Next-Generation Sequencing of Tumor Tissue Versus Blood in Patients with Advanced Urothelial Cancer

Study examines concordance between commercially available genomic tests

September 12, 2016/Cancer/Research

Study Shows Active Surveillance is Safe and Viable in Some Metastatic Renal Cell Carcinoma Patients

Survival for months or several years while delaying treatment is possible

July 15, 2015/Cancer/Tumor Oncology

Improving Prediction of Recurrence Risk in Clear Cell Renal Cell Carcinoma

Researchers validate a 16-gene assay

BackPage 1 of 1Next